Acotec Scientific Holdings Limited (06669.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

7.8x

Market Cap

HKD 1.88B

MomentumView details →

1D Return

−1.96%

YTD Return

−53.78%

RSI (14)

35.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

7.8x

Market Cap

HKD 1.88B

RSI (14)

35.5

MomentumView details →

1D Return

−1.96%

YTD Return

−53.78%

ProfitabilityView details →

Gross Margin

73.89%

Net Margin

18.49%

EBITDA Margin

18.11%

ROE (TTM)

8.07%

ROA (TTM)

6.38%

Asset Turnover

0.35x

GrowthView details →

Revenue YoY

+20.72%

EPS YoY

+122.34%

FCF YoY

+151.99%

Revenue CAGR 3Y

+17.68%

EPS CAGR 3Y

+19.25%

EBITDA YoY

+151.25%

EarningsView details →

EPS (Actual)

−HKD 0.31

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

HKD 0.00

Avg Surprise (4Q)

—

Rev Surprise

115.83%

Capital & dividendView details →

Debt/Equity

0.17x

Current Ratio

5.73x

Quick Ratio

5.19x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

644.63M

Net Income (TTM)

119.18M

Op. CF (TTM)

150.27M

Next earningsMar 29, 2027 →

Latest newsMore news →

Acotec Medical reported an interim net loss of 80.83 million RMB for the six months ended June 2026, swinging from a profit of 88.58 million RMB a year earlier, with revenue down 5.6% to 332 million RMB.4d ago

Acotec Scientific (06669.HK) issued a profit warning, expecting a net loss of not more than 80.9 million RMB for the six months ended June 30, 2026, compared with a profit of 88.6 million RMB in the same period last year, mainly due to non-cash impairment losses and expense provisions of approximately 151 million RMB arising from the termination of the US clinical trial project.23d ago

Similar companies

Inspire Medical Systems, Inc.INSP Butterfly Network, Inc.BFLY 奥精医疗688613.SH Shanghai HeartCare Medical Technology Corporation Limited06609.HK Establishment Labs Holdings Inc.ESTA UFP Technologies, Inc.UFPT Find similar companies →

Latest newsMore news →

Acotec Medical reported an interim net loss of 80.83 million RMB for the six months ended June 2026, swinging from a profit of 88.58 million RMB a year earlier, with revenue down 5.6% to 332 million RMB.4d ago Acotec Scientific (06669.HK) issued a profit warning, expecting a net loss of not more than 80.9 million RMB for the six months ended June 30, 2026, compared with a profit of 88.6 million RMB in the same period last year, mainly due to non-cash impairment losses and expense provisions of approximately 151 million RMB arising from the termination of the US clinical trial project.23d ago